|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Loss on sale | |||||
| Loss (gain) on equity securities | |||||
| Loss (gain) on indexed debt securities | |||||
| Equity in earnings of unconsolidated affiliates | |||||
| Distributions from unconsolidated affiliates | |||||
| Pension and postretirement contributions | |||||
| Changes in other assets and liabilities: | |||||
| Accounts receivable and unbilled revenues, net | |||||
| Inventory | |||||
| Taxes receivable | |||||
| Accounts payable | |||||
| Net regulatory assets and liabilities | |||||
| Current regulatory assets and liabilities | |||||
| Non-current regulatory assets and liabilities | |||||
| Total net regulatory assets and liabilities | |||||
| Other current assets and liabilities | |||||
| Other non-current assets and liabilities | |||||
| Other current assets | |||||
| Other current liabilities | |||||
| Other non-current assets | |||||
| Other non-current liabilities | |||||
| Other operating activities, net | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Transaction costs related to Enable Merger (Note 4) | |||||
| Cash received related to Enable Merger | |||||
| Proceeds from sale of equity securities, net of transaction costs | |||||
| Capital expenditures | |||||
| Payment for asset acquisition | |||||
| Proceeds from divestitures | |||||
| Other investing activities, net | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Decrease in short-term borrowings, net | |||||
| Payment of obligation for finance lease | |||||
| Payments of commercial paper, net | |||||
| Proceeds from long-term debt and term loans, net | |||||
| Payments of long-term debt and term loans, including make-whole premiums | |||||
| Payment of debt issuance costs | |||||
| Payment of dividends on Common Stock | |||||
| Payment of dividends on Preferred Stock | |||||
| Redemption of Series A Preferred Stock | |||||
| Other financing activities, net | |||||
| Net cash provided by financing activities | |||||
| Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash | |||||
| Cash, Cash Equivalents and Restricted Cash at Beginning of Period | |||||
| Cash, Cash Equivalents and Restricted Cash at End of Period | |||||
Loading...